Compliance Rate
Compliance Rate
50.0%
Compliant submissions
1
Incompliant submissions
1
Total trials
2
My Organizations' Clinical Trials
Showing 3175 of 3499 entries
View as:
Phase: N/A
Priority: Normal
Start: 11/30/04
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 04/30/04
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 08/19/94
End: 02/26/18
Due: 02/26/19
Phase: N/A
Priority: Normal
Start: 06/03/02
End: 07/31/18
Due: 07/31/19
Phase: N/A
Priority: Normal
Start: 04/07/06
End: 03/23/11
Due: 03/23/12
Phase: N/A
Priority: Normal
Start: 12/14/19
End: 04/16/26
Due: 04/16/27
Phase: N/A
Priority: Normal
Start: 02/14/11
End: 08/15/23
Due: 08/15/24
Phase: N/A
Priority: Normal
Start: 03/31/07
End: 08/31/10
Due: 08/31/11
Phase: N/A
Priority: Normal
Start: 06/30/06
End: 03/31/09
Due: 03/31/10
Bryostatin 1 Plus Vincristine in Treating Patients With Recurrent or Refractory HIV-Related Lymphoma
Phase: N/A
Priority: Normal
Start: 11/30/01
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 07/17/01
End: 02/19/09
Due: 02/19/10
Phase: N/A
Priority: Normal
Start: 09/30/05
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 06/01/10
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 04/30/03
End: 02/28/10
Due: 02/28/11
Phase: N/A
Priority: Normal
Start: 05/14/19
End: 03/22/22
Due: 03/22/23
Phase: N/A
Priority: Normal
Start: 02/01/07
End: 04/22/14
Due: 04/22/15
Phase: N/A
Priority: Normal
Start: 01/31/07
End: 01/31/11
Due: 01/31/12
Phase: N/A
Priority: Normal
Start: 11/30/01
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 08/29/11
End: 09/23/16
Due: 09/23/17
Phase: N/A
Priority: Normal
Start: 11/16/20
End: 12/09/25
Due: 12/09/26
Phase: N/A
Priority: Normal
Start: 03/11/20
End: 09/06/22
Due: 09/06/23
Phase: N/A
Priority: Normal
Start: 04/11/16
End: 09/08/21
Due: 09/08/22
Phase: N/A
Priority: Normal
Start: 10/15/21
End: 06/30/26
Due: 06/30/27
Phase: N/A
Priority: Normal
Start: 06/30/10
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 08/31/99
End: 04/30/02
Due: 04/30/03